These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1493 related items for PubMed ID: 18580014

  • 1. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 2. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [Abstract] [Full Text] [Related]

  • 4. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 5. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 6. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Nov; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 7. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Mar 15; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov 15; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 10. Kidney transplantation, the Halifax experience.
    Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B, West K, Sketris I.
    Clin Transpl; 1996 Nov 15; ():231-40. PubMed ID: 9286572
    [Abstract] [Full Text] [Related]

  • 11. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y, Kishikawa H, Nishimura K, Tokugawa S, Yoshioka I, Arichi N, Fujii N, Kyo M, Nishikawa M.
    Transplant Proc; 2006 Dec 15; 38(10):3451-3. PubMed ID: 17175300
    [Abstract] [Full Text] [Related]

  • 12. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G, Döhler B, Collaborative Transplant Study.
    Transplantation; 2009 Mar 27; 87(6):795-802. PubMed ID: 19300179
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 27; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 14. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X, Johnston A.
    Transplant Proc; 2004 Jun 27; 36(5):1321-6. PubMed ID: 15251323
    [Abstract] [Full Text] [Related]

  • 15. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar 27; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov 27; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 17. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A, Woo KT.
    Clin Transpl; 1999 Nov 27; ():189-97. PubMed ID: 11038637
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 19. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep 27; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.